NCT00790153View on ClinicalTrials.gov

To Evaluate the Hormonal Response to Low Blood Sugar After a Single Oral Dose of AZD1656 Suspension

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

November 30, 2008

Study Completion Date

February 28, 2009

Conditions

Type 2 Diabetes

Interventions

DRUG

Insulin

Insulin infusion given during 3 hours at one occasion.

DRUG

AZD1656

Single dose oral suspension given at one occasion.

Trial Locations (1)

Unknown

Research Site, Chula Vista

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY